• Skip to main content

Parkinson’s Treatment Report

www.ParkinsonsTreatmentReport.com

GZ/SAR402671

A Global Study to Assess the Drug Dynamics, Efficacy, and Safety of GZ/SAR402671 in Parkinson’s Disease Patients Carrying a Glucocerebrosidase (GBA) Gene Mutation

May 22, 2019

https://clinicaltrials.gov/ct2/show/NCT02906020?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F08%2F2019&lupd_d=14&sort=nwst

STUDY TITLE:
A Global Study to Assess the Drug Dynamics, Efficacy, and Safety of GZ/SAR402671 in Parkinson’s Disease Patients Carrying a Glucocerebrosidase (GBA) Gene Mutation

DESCRIPTION:
Condition:   Parkinson’s Disease
Interventions:   Drug: GZ/SAR402671;   Drug: Placebo
Sponsor:   Genzyme, a Sanofi Company
Recruiting

CLINICALTRIALS.GOV IDENTIFIER:
NCT02906020

FIRST POSTED:
Mon, 19 Sep 2016 12:00:00 EDT

LAST UPDATE POSTED:
05/22/19 07:42AM

STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT02906020?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F08%2F2019&lupd_d=14&sort=nwst

Powered by Urgent Research

Copyright © 2025 Urgent Research